Tag: pharmaceutical patents
Market Exclusivity Extensions: Mechanisms Beyond Patents Explained
Maddie Shepherd
Aug
11
0
Comments
Explore how pharmaceutical companies extend market dominance beyond patent expiration using regulatory exclusivities like PTE, SPCs, and orphan drug protections in the US and EU.
More Detail
Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Maddie Shepherd
Jul
13
11
Comments
Learn how orphan drug exclusivity protects rare-disease medicines in the US and EU. Discover the 7-year market protection rules, the 'dyad' concept, and how it differs from patents.
More Detail